CERo Therapeutics Holdings Inc

CERO30 Nov 2024
Healthcare
$0.2
-0.05 (-4.60%)
Lowest Today
$0.18
Highest Today
$0.21
Today’s Open
$0.2
Prev. Close
$0.2
52 Week High
$12.8
52 Week Low
$0.06
To Invest in CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings Inc

Healthcare
CERO30 Nov 2024
-0.05 (-4.60%)
1M
3M
6M
1Y
5Y
Low
$0.18
Day’s Range
High
$0.21
0.18
52 Week Low
$0.06
52-Week Range
52 Week High
$12.8
0.06
1 Day
-
1 Week
+9.89%
1 month return
+131.79%
3 month return
+50.15%
6 month return
-80.9%
1 Year return
-
3 Years return
-98.08%
5 Years return
-
10 Years return
-
Fundamentals
Market Cap
4.79 mln
PB Ratio
0
PE Ratio
0
Enterprise Value
12.73 mln
Total Assets
8.56 mln
Volume

Fund house & investment objective

Company Information
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.
Organisation
CERo Therapeutics Holdings Inc
Employees
8
Industry
Biotechnology
CEO
Mr. Christopher B. Ehrlich M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities